| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0087 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |